Views & Analysis The happiness factor As part of pharmaphorum’s Eye on Innovation series, Richard Staines spoke to John Zibert, chief medical officer at LEO Pharma’s Innovation lab, about how the company wants to develop produc
Oncology BioNTech’s ASCO 2025 oncology advances: New data on bispecif... At ASCO 2025, BioNTech presented 7 abstracts on four selected pipeline candidates in mesothelioma, lung cancer, prostate cancer, and melanoma.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face